Four genes indentified that influence levels of 'bad' cholesterol
Scientists at the Texas Biomedical Research Institute in San Antonio have identified four genes in baboons that influence levels of "bad" cholesterol. This discovery could lead to the development of new drugs to reduce the ...
Medical research
May 15, 2013 |
4.5 / 5 (2) |
0
|
Taking cholesterol-lowering drugs may also reduce the risk of dying from prostate cancer, study finds
Men with prostate cancer who take cholesterol-lowering drugs called statins are significantly less likely to die from their cancer than men who don't take such medication, according to study led by researchers at Fred Hutchinson ...
Cancer
May 02, 2013 |
not rated yet |
1
Regional anesthesia technique significantly improves outcomes of hip and knee replacement
A highly underutilized anesthesia technique called neuraxial anesthesia, also known as spinal or epidural anesthesia, improves outcomes in patients undergoing hip or knee replacement, according to a new study ...
Surgery
May 01, 2013 |
not rated yet |
0
Monthly shot lowers cholesterol 66 percent: study
A monthly injection of an experimental drug made by the US biotech firm Amgen reduced patients' cholesterol by up to 66 percent, according to a small study described at a US cardiology conference.
Cardiology
Mar 26, 2012 |
5 / 5 (2) |
5
Tart cherries linked to reduced risk of stroke
(Medical Xpress)—For the millions of Americans at risk for heart disease or diabetes, a diet that includes tart cherries might actually be better than what the doctor ordered, according to new animal research ...
Health
Apr 24, 2013 |
3.8 / 5 (4) |
0
|
The cost of prescription drugs—a comparison of two countries
In the United States, the cost paid for statins (drugs to lower cholesterol) in people under the age of 65 who have private insurance continues to exceed comparable costs paid by the government in the United Kingdom (U.K.) ...
Medications
Nov 01, 2012 |
3.7 / 5 (3) |
1
Study finds no link between statins and cancer risk
(Medical Xpress) -- A new study published in the Journal of the American College of Cardiology reports that, contrary to previous studies, the use of cholesterol reducing statin drugs does not increase the risk of patien ...
Cancer
Jul 25, 2011 |
5 / 5 (2) |
0
|
Niacin therapy unhelpful, occasionally harmful, study says
A combination drug containing niacin failed to lower the risk of heart attacks or strokes and even proved harmful for some with vascular disease, a study released Saturday reported.
Cardiology
Mar 09, 2013 |
4 / 5 (1) |
0
Personalized plans to address barriers to HIV drug adherence boost chances of successful therapy
HIV patients who participated in an intervention that helped them identify barriers to taking their drugs properly and develop customized coping strategies took a significantly greater amount of their prescribed doses than ...
HIV & AIDS
Jan 29, 2013 |
5 / 5 (1) |
0
|
Scientists find a new way to boost common cancer drugs
Shutting down a specific pathway in cancer cells appears to improve the ability of common drugs to wipe those cells out, according to new research from scientists at Fox Chase Cancer Center, published in the January issue ...
Cancer
Jan 14, 2013 |
5 / 5 (2) |
0
|
Canadian scientists discover cause of high cholesterol
Canadian scientists have discovered that a protein called resistin, secreted by fat tissue, causes high levels of "bad" cholesterol (low-density lipoprotein or LDL), increasing the risk of heart disease.
Medical research
Oct 28, 2012 |
3 / 5 (1) |
0
Medical studies with striking results often prove false
If a medical study seems too good to be true, it probably is, according to a new analysis.
Cancer
Oct 24, 2012 |
4 / 5 (1) |
2
Overlooked ugly cholesterol causes heart disease
The risk of ischaemic heart disease – a disease affecting some 150,000 Danes – is three times higher in persons with high levels of the so-called 'ugly' cholesterol. This is the finding of a new study of 73,000 Danes, ...
Cardiology
Jan 21, 2013 |
2.5 / 5 (2) |
0
Cholesterol rafts deliver drugs inside cancer cells
DNA, siRNA and miRNA can reprogram cancer cells – that is, if these nucleic acids could cross through the cell membrane. A University of Colorado Cancer Center study published today in the journal Therapeutic Delivery shows ...
Cancer
Apr 02, 2013 |
4.5 / 5 (2) |
0
|
Researchers find alternative cholesterol-lowering drug for patients who can't tolerate statins
Heart patients who can't tolerate the side effects of cholesterol-lowering drugs may have a new option, according to a new study by researchers from the Intermountain Heart Institute at Intermountain Medical Center in Salt ...
Cardiology
Mar 11, 2013 |
5 / 5 (2) |
0
